ARCHIVES

Healy Comes To Defense Of NCI’s Robert Wittes; Official Has Been Target Of Innuendo Over Taxo

This article is from The Cancer Letter archive.

Vol. 18 No. 35 | September 11, 1992

Download PDF Visit The Full Archive

Related Articles

FDA Approves Xeloda For Breast Cancer After Failure Of Anthracycline Treatment.

September 28, 2001

Reaction: Voices Of Believers Drown Out Skeptics

November 20, 2009

AACR President: Cancer Program ‘Threatened,’ Calls For Strategic Plan, More Extramural Input

December 6, 1991

FOLFOX 4 Should Be First-Line Therapy For Advanced Disease, NCCTG Finds

December 26, 2003

Inhibitor Reduces Spleen Size By 35 Percent or More in Phase III

June 28, 2013

Congress Agrees On Jackson Lab Support, But does Not Add Money; Earmarks Hit NCI Budget

October 27, 1989